![Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis | Protocol (Translated to Arabic) Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis | Protocol (Translated to Arabic)](https://www.jove.com/files/ftp_upload/60776/60776fig02large.jpg)
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis | Protocol (Translated to Arabic)
![Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis | Protocol (Translated to Arabic) Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis | Protocol (Translated to Arabic)](https://www.jove.com/files/ftp_upload/60776/60776fig03large.jpg)
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis | Protocol (Translated to Arabic)
![التحديات والحلول للحد من مخاطر العدوى عند إدخال القسطرات الوعائية - Anesthesia Patient Safety Foundation التحديات والحلول للحد من مخاطر العدوى عند إدخال القسطرات الوعائية - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/newsletters/2022/0501-ar/table-1-dncc-ols-ar.jpg)